Onconova Therapeutics- Warrants (01/08/2021) Profit Margin

Onconova Therapeutics- Warrants (01/08/2021)'s profit margin stands at 321546.12% as of March 2026. That compares with -8797.22% in the prior-year period — up 3755.1% year over year. That is above the Healthcare sector average of 13.71%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Onconova Therapeutics- Warrants (01/08/2021) reported 321546.12% in profit margin versus -8797.22% a year earlier — a 3755.1% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Onconova Therapeutics- Warrants (01/08/2021) sits higher the Healthcare benchmark (13.71%) with a profit margin of 321546.12%. That is roughly 2345095.6% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 321546.12% for Onconova Therapeutics- Warrants (01/08/2021) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Onconova Therapeutics- Warrants (01/08/2021)'s profit margin evolved across reporting periods, while the comparison chart places ONTXW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.